Daniel OToole
Overview
Explore the profile of Daniel OToole including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1033
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cosgrave D, McNicholas B, Hanley C, Sheehan J, Calpin P, Kernan M, et al.
Intensive Care Med Exp
. 2025 Feb;
13(1):15.
PMID: 39920521
Background: Nebulised unfractionated heparin may attenuate COVID-19 ARDS by reducing pulmonary microvascular thrombosis, blocking SARS-CoV-2 entry into cells, and decreasing lung inflammation. COVID-19 patients with a raised D-dimer have areas...
2.
OToole D, Horie S, Murphy E
Front Med (Lausanne)
. 2024 Nov;
11:1496821.
PMID: 39564505
No abstract available.
3.
Donoghue M, Wang H, OToole D, Connelly C, Horie S, Woulfe P, et al.
Sci Rep
. 2024 Oct;
14(1):23745.
PMID: 39390031
The study of biological soft tissue structures at the micron scale details the function of healthy and pathological tissues, which is vital in the diagnosis and treatment of diseases. Speckle...
4.
Liu L, Fandino J, McCarthy S, Masterson C, Sallent I, Du S, et al.
Cells
. 2024 Sep;
13(18.
PMID: 39329762
Background: Despite promise in preclinical models of acute respiratory distress syndrome (ARDS), mesenchymal stem cells (MSC) have failed to translate to therapeutic benefit in clinical trials. The MSC is a...
5.
Vishwanath N, Cummings O, Lim J, Kulkarni S, Sobti N, OToole D, et al.
Ann Plast Surg
. 2024 Apr;
92(4S Suppl 2):S298-S304.
PMID: 38556693
Background: Presentations are an important means of knowledge generation. Publication of these studies is important for dissemination of findings beyond meeting attendees. We analyzed a 10-year sample of presented abstracts...
6.
Francalancia S, Soliman L, OToole D, Woo A
Dermatol Surg
. 2023 Oct;
50(8):753-755.
PMID: 37890012
No abstract available.
7.
McCarthy S, Tilbury M, Masterson C, MacLoughlin R, Gonzalez H, Laffey J, et al.
J Aerosol Med Pulm Drug Deliv
. 2023 Aug;
36(5):246-256.
PMID: 37638822
Acute respiratory distress syndrome (ARDS) is a life-threatening respiratory failure syndrome with diverse etiologies characterized by increased permeability of alveolar-capillary membranes, pulmonary edema, and acute onset hypoxemia. During the ARDS...
8.
Byrnes D, Masterson C, Brady J, Horie S, McCarthy S, Gonzalez H, et al.
Front Med (Lausanne)
. 2023 Jul;
10:1132749.
PMID: 37469663
Introduction: Mesenchymal stromal cells (MSC) are a promising therapeutic for pneumonia-induced sepsis. Here we sought to determine the efficacy of delayed administration of naïve and activated bone marrow (BM), adipose...
9.
Gonzalez H, McCarthy S, Masterson C, Laffey J, MacLoughlin R, OToole D
Front Med (Lausanne)
. 2023 Jun;
10:1162615.
PMID: 37332742
Background: Mesenchymal stem cells (MSC) have shown immense therapeutic promise in a range of inflammatory diseases, including acute respiratory distress syndrome (ARDS), and are rapidly advancing through clinical trials. Among...
10.
Gonzalez H, McCarthy S, Masterson C, Byrnes D, Sallent I, Horan E, et al.
Stem Cell Res Ther
. 2023 Jun;
14(1):151.
PMID: 37280647
Background: Mesenchymal stem cell (MSC) derived extracellular vesicles (EVs) have been proposed as an alternative to cell therapy, creating new possible delivery modalities such as nebulisation. We wished to investigate...